Table 1 Clinical features of all episodes of PA-BSI included in this study.
Clinical and demographic characteristicsa | Number of episodes (%) | p-valueb | |||
|---|---|---|---|---|---|
TOTAL (n = 78) | Pre-COVID (n = 48) | Post-COVID (n = 30) | |||
Sex | 1 | ||||
Male | 49 (63) | 31 (65) | 18 (60) | ||
Female | 29 (37) | 17 (35) | 12 (40) | ||
Age (y.o.) | 72.4 ± 3.5 | 71.1 ± 4.3 | 74.4 ± 6.0 | 0.385 | |
Service | Oncology/Haematology | 18 (23.1) | 11 (22.9) | 7 (23.3) | 1 |
Infectious diseases | 15 (19.2) | 9 (18.8) | 6 (20.0) | 1 | |
General Internal Medicine | 12 (15.4) | 5 (10.4) | 7 (23.3) | 0.196 | |
ICU | 10 (12.8) | 6 (12.5) | 4 (13.3) | 1 | |
Digestive | 6 (7.7) | 4 (8.3) | 2 (6.7) | 1 | |
Urology | 5 (6.4) | 3 (6.3) | 2 (6.7) | 1 | |
Palliative care | 3 (3.8) | 3 (6.3) | 0 (0) | 0.281 | |
Surgery | 3 (3.8) | 3 (6.3) | 0 (0) | 0.281 | |
Geriatrics | 2 (2.6) | 1 (2.1) | 1 (3.3) | 1 | |
Gynaecology | 1 (1.3) | 1 (2.1) | 0 (0) | 1 | |
Pneumology | 1 (1.3) | 1 (2.1) | 0 (0) | 1 | |
Cardiology | 1 (1.3) | 1 (2.1) | 0 (0) | 1 | |
Home hospitalization | 1 (1.3) | 0 (0) | 1 (3.3) | 0.385 | |
Type of acquisition | Hospital acquired | 34 (43.6) | 23 (47.9) | 11 (36.7) | 0.346 |
Health care associated | 34 (43.6) | 20 (41.7) | 14 (46.7) | 0.817 | |
Community acquired | 8 (10.2) | 3 (6.25) | 5 (16.7) | 0.143 | |
N/A | 2 (2.6) | 2 (4.2) | 0 (0) | ||
Source of infection | Abdominal | 18 (23.1) | 11 (22.9) | 7 (23.3) | 1 |
UTI | 17 (21.8) | 10 (20.8) | 7 (23.3) | 0.786 | |
Unclear | 15 (19.2) | 10 (20.8) | 5 (16.7) | 0.772 | |
STI | 8 (10.3) | 4 (8.3) | 4 (13.3) | 0.476 | |
Respiratory | 7 (9.0) | 3 (6.3) | 4 (13.3) | 0.419 | |
Catheter | 6 (7.7) | 3 (6.3) | 3 (10.0) | 0.67 | |
Phlebitis | 5 (6.4) | 5 (10.4) | 0 (0) | 0.15 | |
Bacterial superinfection | 1 (1.3) | 1 (2.1) | 0 (0) | 1 | |
Abscess | 1 (1.3) | 1 (2.1) | 0 (0) | 1 | |
Exitus | 0.817 | ||||
Yes | 41 (53) | 26 (54) | 15 (50) | ||
No | 37 (47) | 22 (46) | 15 (50) | ||
